FDA Inspection Uncovers Major Supply Chain Weaknesses in the Pharmaceutical Sector
An FDA inspection has revealed critical vulnerabilities in the pharmaceutical supply chain, prompting immediate action from manufacturers to enhance compliance and quality assurance.
Yahoo Finance
3 min read
Healthcare
Pharmaceuticals
Regulatory Affairs